2-(Cyclohexyloxy)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

Catalog No. :
ACWXVZ531
CAS No. :
1346707-98-9
Molecular Formula :
C17H26BNO3
Molecular Weight :
303.21

IUPAC Name:2-(cyclohexyloxy)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

2-(Cyclohexyloxy)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$579.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Cyclohexyloxy)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
IUPAC Name2-(cyclohexyloxy)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
MDL No.MFCD12032391
Molecular FormulaC17H26BNO3
Molecular Weight303.21
SMILESCC1(C)C(C)(C)OB(C2=CC(OC3CCCCC3)=NC=C2)O1
InChI KeyPOAHQORTFYQKDX-UHFFFAOYSA-N
Synonym2-(cyclohexyloxy)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;Pyridine, 2-(cyclohexyloxy)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.1346707-98-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACWXVZ531 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPNVO357 route compound structure diagram
    ACPNVO357458532-84-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWXVZ531 route product structure diagram
    ACWXVZ5311346707-98-9
Inquiry

2. ACWXVZ531 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACWXVZ531 route product structure diagram
    ACWXVZ5311346707-98-9
Inquiry

Comments (0)